Annual Cash & Cash Equivalents
$682.20 K
-$4.51 M-86.87%
01 June 2024
Summary:
Genetic Technologies Limited annual cash & cash equivalents is currently $682.20 thousand, with the most recent change of -$4.51 million (-86.87%) on 01 June 2024. During the last 3 years, it has fallen by -$15.02 million (-95.66%). GENE annual cash & cash equivalents is now -95.66% below its all-time high of $15.70 million, reached on 30 June 2021.GENE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$682.20 K
-$1.86 M-73.15%
01 June 2024
Summary:
Genetic Technologies Limited quarterly cash and cash equivalents is currently $682.20 thousand, with the most recent change of -$1.86 million (-73.15%) on 01 June 2024. Over the past year, it has dropped by -$1.86 million (-73.15%). GENE quarterly cash and cash equivalents is now -95.66% below its all-time high of $15.70 million, reached on 30 June 2021.GENE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GENE Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -86.9% | -73.2% |
| 3 y3 years | -95.7% | -95.7% |
| 5 y5 years | -54.3% | -54.3% |
GENE Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -95.7% | at low | -95.7% | at low |
| 5 y | 5 years | -95.7% | at low | -95.7% | at low |
| alltime | all time | -95.7% | at low | -95.7% | at low |
Genetic Technologies Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | $682.20 K(-86.9%) | $682.20 K(-73.1%) |
| Dec 2023 | - | $2.54 M(-51.1%) |
| June 2023 | $5.20 M(-35.6%) | $5.20 M(+51.4%) |
| Dec 2022 | - | $3.43 M(-57.5%) |
| June 2022 | $8.07 M(-48.6%) | $8.07 M(-17.6%) |
| Dec 2021 | - | $9.79 M(-37.7%) |
| June 2021 | $15.70 M(+60.8%) | $15.70 M(+24.3%) |
| Dec 2020 | - | $12.64 M(+29.4%) |
| June 2020 | $9.77 M(+554.2%) | $9.77 M(+325.7%) |
| Dec 2019 | - | $2.29 M(+53.7%) |
| June 2019 | $1.49 M(-63.0%) | $1.49 M(-34.5%) |
| Dec 2018 | - | $2.28 M(-43.5%) |
| June 2018 | $4.03 M(-52.3%) | $4.03 M(-32.0%) |
| Dec 2017 | - | $5.92 M(-29.9%) |
| June 2017 | $8.44 M(+1.1%) | $8.44 M(-22.2%) |
| Dec 2016 | - | $10.85 M(+30.0%) |
| June 2016 | $8.35 M(-40.7%) | $8.35 M(-21.0%) |
| Dec 2015 | - | $10.57 M(-24.9%) |
| June 2015 | $14.07 M(+427.8%) | $14.07 M(+1248.8%) |
| Dec 2014 | - | $1.04 M(-60.9%) |
| June 2014 | $2.67 M | $2.67 M(-63.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | - | $7.33 M(+358.8%) |
| June 2013 | $1.60 M(-82.1%) | $1.60 M(-74.1%) |
| Dec 2012 | - | $6.17 M(-30.9%) |
| June 2012 | $8.93 M(+63.7%) | $8.93 M(-30.0%) |
| Dec 2011 | - | $12.76 M(+133.9%) |
| June 2011 | $5.46 M(+96.2%) | $5.46 M(-36.3%) |
| Dec 2010 | - | $8.56 M(+207.8%) |
| June 2010 | $2.78 M(-55.9%) | $2.78 M(-44.3%) |
| Dec 2009 | - | $5.00 M(-20.8%) |
| June 2009 | $6.31 M(-49.0%) | $6.31 M(-16.6%) |
| Dec 2008 | - | $7.56 M(-38.9%) |
| June 2008 | $12.37 M(+9.5%) | $12.37 M(+2.2%) |
| Dec 2007 | - | $12.11 M(+7.2%) |
| June 2007 | $11.30 M(+43.0%) | $11.30 M(+50.4%) |
| Dec 2006 | - | $7.51 M(-5.0%) |
| June 2006 | $7.90 M(-41.2%) | $7.90 M(-31.4%) |
| Dec 2005 | - | $11.53 M(-14.3%) |
| June 2005 | $13.45 M(+70.9%) | $13.45 M(+58.6%) |
| Dec 2004 | - | $8.48 M |
| June 2004 | $7.87 M(+101.7%) | - |
| June 2003 | $3.90 M(+432.5%) | - |
| June 2000 | $733.10 K | - |
FAQ
- What is Genetic Technologies Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Genetic Technologies Limited?
- What is Genetic Technologies Limited annual cash & cash equivalents year-on-year change?
- What is Genetic Technologies Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Genetic Technologies Limited?
- What is Genetic Technologies Limited quarterly cash and cash equivalents year-on-year change?
What is Genetic Technologies Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of GENE is $682.20 K
What is the all time high annual cash & cash equivalents for Genetic Technologies Limited?
Genetic Technologies Limited all-time high annual cash & cash equivalents is $15.70 M
What is Genetic Technologies Limited annual cash & cash equivalents year-on-year change?
Over the past year, GENE annual cash & cash equivalents has changed by -$4.51 M (-86.87%)
What is Genetic Technologies Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GENE is $682.20 K
What is the all time high quarterly cash and cash equivalents for Genetic Technologies Limited?
Genetic Technologies Limited all-time high quarterly cash and cash equivalents is $15.70 M
What is Genetic Technologies Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, GENE quarterly cash and cash equivalents has changed by -$1.86 M (-73.15%)